Thymidine phosphorylase expression in human colorectal mucosa, adenoma and carcinoma: Role of p53 expression

Pathology International

Volumn 49, Issue 6, 1999, Pages 491-499

  Shomori, Kohei ^a   Sakatani, Takashi ^a   Goto, Akira ^a   Matsuura, Takahiko ^a   Kiyonari, Hiroshi ^a   Ito, Hisao ^a,b  

^a TOTTORI UNIVERSITY   (Japan)

^b TOTTORI UNIVERSITY   (Japan)

Author keywords

Angiogenesis; Colorectal carcinoma; Immunohistochemistry; P53; Thymidine phosphorylase

Indexed keywords

ANGIOGENIC FACTOR; PLATELET DERIVED ENDOTHELIAL CELL GROWTH FACTOR; PROTEIN P53; THYMIDINE PHOSPHORYLASE;

ANGIOGENESIS; ARTICLE; CANCER CELL CULTURE; COLON ADENOMA; COLON CARCINOMA; COLON MUCOSA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE; MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECTUM MUCOSA; STROMA CELL; TISSUE DISTRIBUTION;

ADENOMA; ANTIBODIES, MONOCLONAL; BLOTTING, WESTERN; CARCINOMA; COLORECTAL NEOPLASMS; HUMANS; IMMUNOENZYME TECHNIQUES; INTESTINAL MUCOSA; THYMIDINE PHOSPHORYLASE; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032844212     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1827.1999.00897.x     Document Type: Article

References (47)

1. 1 Iltzsch MH, El-Kouni MH, Cha S. Kinetic studies of thymidine phosphorylase from mouse liver. Biochemistry 1985; 24: 6799-6807.
2. 2 Krenitsky TA, Koszalka GW, Tuttle JV. Purine nucleoside synthesis, an efficient method employing nucleoside phosphorylase. Biochemistry 1981; 20: 3615-3621.
3. 3 Zimmerman M, Seidenberg J. Deoxyribosyl transfer. J. Biol. Chem. 1964; 239: 2618-2621.
4. 4 Krenitsky TA. Pentosyl transfer mechanisms of the mammalian nucleoside phosphorylase. J. Biol. Chem. 1968; 243: 2871-2875.
5. 5 Sumizawa T, Furukawa T, Haraguchi M et al. Thymidine phosphorylase activity associated with platelet-derived endothelial cell growth factor. J. Biochem.(Tokyo) 1993; 114: 9-14.
6. 6 Haraguchi M, Miyadera K, Uemura K et al. Angiogenic activity of enzymes. Nature 1994; 368: 198.
7. 7 Ishikawa F, Miyazono K, Hellman U et al. Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor. Nature 1989; 338: 557-562.
8. 8 Miyadera K, Sumizawa T, Haraguchi M et al. Role of thymidine phosphorylase activity in the angiogenic effect of platelet-derived endothelial cell growth factor/thymidine phosphorylase. Cancer Res. 1995; 55: 1687-1690.
9. 9 Stevenson DP, Milligan SR, Collins WP. Effects of platelet-derived endothelial cell growth factor/thymidine phosphorylase, substrate, and products in a three-dimensional model of angiogenesis. Am. J. Pathol. 1998; 152: 1641-1646.
10. 10 Takebayashi Y, Yamada K, Miyadera K et al. The activity and expression of thymidine phosphorylase in human solid tumours. Eur. J. Cancer 1996; 32: 1227-1232.
11. 11 Takebayashi Y, Miyadera K, Akiyama S et al. Expression of thymidine phosphorylase in human gastric carcinoma. Jpn. J. Cancer Res. 1996; 87: 288-295.
12. 12 Maeda K, Chung Y-S, Ogawa Y et al. Thymidine phosphorylase/platelet-derived endothelial cell growth factor expression associated with hepatic metastasis in gastric carcinoma. Br. J. Cancer 1996; 73: 884-888.
13. 13 Takebayashi Y, Yamada K, Maruyama I, Fujii R, Akiyama S, Aikou T. The expression of thymidine phosphorylase and thrombomodulin in human colorectal carcinomas. Cancer Lett. 1995; 92: 1-7.
14. 14 Takebayashi Y, Akiyama S, Akiba S et al. Clinicopathologic and prognostic significance of an angiogenic factor, thymidine phosphorylase, in human cotorectal carcinoma. J. Natl Cancer Inst. 1996; 88: 1110-1117.
15. 15 Takao S, Takebayashi Y, Che X et al. Expression of thymidine phosphorylase is associated with a poor prognosis in patients with ductal adenocarcinoma of the pancreas. Clin. Cancer Res. 1998; 4: 1619-1624.
16. 16 Toi M, Hoshina S, Taniguchi T, Yamamoto Y, Ishitsuka H, Tominaga T. Expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human breast cancer. Int. J. Cancer 1995; 64: 79-82.
17. 17 Yonenaga F, Takasaki T, Ohi Y et al. The expression of thymidine phosphorylase/platelet-derived endothelial cell growth factor is correlated to angiogenesis in breast cancer. Pathol. Int. 1998; 48: 850-856.
18. 18 O'Brien T, Cranston D, Fuggle S, Bicknell R, Harris AL. Different angiogenic pathways characterize superficial and invasive bladder cancer. Cancer Res. 1995; 55: 510-513.
19. 19 Kakizoe T, ed. Cancer Statistics in Japan, 1997: Foundation for Promotion of Cancer Research, Tokyo, Japan 1997.
20. 20 Lenz H-J, Hayashi K, Salonga D et al. p53 point mutations and thymidylate synthase messenger RNA levels in disseminated colorectal cancer: An analysis of response and survival. Clin. Cancer Res. 1998; 4: 1243-1250.
21. 21 Yeh K-H, Shun C-T, Chen C-L et al. High expression of thymidylate synthase is associated with the drug resistance of gastric carcinoma to high dose 5-fluorouracil-based systemic chemotherapy. Cancer 1998; 82: 1626-1631.
22. 22 Mirjolet J-F, Barberi-Heyob M, Merlin J-L et al. Thymidylate synthase expression and activity: Relation to S-phase parameters and 5-fluorouracil sensitivity. Br. J. Cancer 1998; 78: 62-68.
23. 23 Japanese Research Society for Cancer of Colon and Rectum. General Rules for Clinical and Pathological Studies on Cancer of Colon Rectum and Anus, 5th edn. Kanahara Shuppan, Tokyo; 1994 (in Japanese).
24. 24 Kyriakos M. The President's cancer, the Dukes classification, and confusion. Arch. Pathol. Lab. Med. 1985; 109: 1063-1066.
25. 25 Hayashi H, Tatebe S, Osaki M, Goto A, Sato K, Ito H. Anti-Fas antibody-induced apoptosis in human colorectal carcinoma cell lines: Role of the p53 gene. Apoptosis 1999 (in press).
26. 26 Rodrigues NR, Rowan A, Smith MEF et al. p53 mutations in colorectal cancer. Proc. Natl Acad. Sci. USA 1990; 87: 7555-7559.
27. 27 Pocard M, Chevillard S, Villaudy J, Poupon MF, Dutrillaux B, Rermvikos Y. Different p53 mutations produce distinct effects on the ability of colon carcinoma cells to become blocked at the G1/S boundary after irradiation. Oncogene 1996; 12: 875-882.
28. 28 Tahara E, Yamamoto S, Yasui W, Yokozaki H, Tahara H. Telomerase activity and genetic changes in human colorectal cancers. In: Baba S, ed. New Strategies for Treatment of Hereditary Colorectal Cancer. Churchill Livingstone, Tokyo, 1996; 63-69.
29. 29 Nishida M, Hino A, Mori K, Matsumoto T, Yoshikubo T, Ishitsuka H. Preparation of anti-human thymidine phosphorylase monoclonal antibodies useful for detecting the enzyme levels in tumor tissues. Biol. Pharm. Bull. 1996; 19: 1407-1411.
30. 30 Hollingsworth HQ, Kohn EC, Steinberg SM, Rothenberg MIL, Merino MJ. Tumor angiogenesis in advanced stage ovarian carcinoma. Am. J. Pathol. 1995; 147: 33-41.
31. 31 Tanigawa N, Amaya H, Matsumura M et al. Extent of tumor vascularization correlates with prognosis and hematogenous metastasis in gastric carcinomas. Cancer Res. 1996; 56: 2671-2676.
32. 32 Hsu S-M, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures. J. Histochem. Cytochem. 1981; 29: 577-580.
33. 33 Weidner N, Semple JP, Welch WIR, Folkman J. Tumor angiogenesis and metastasis: Correlation in invasive breast carcinoma. N. Engl. J. Med. 1991; 324: 1-8.
34. 34 Yoshimura A, Kuwazuru Y, Furukawa T, Yoshida H, Yamada K, Akiyama S. Purification and tissue distribution of human thymidine phosphorylase; high expression in lymphocytes, reticulocytes and tumors. Biochim. Biophys. Acta 1990; 1034: 107-113.
35. 35 Fox SB, Moghaddam A, Westwood M et al. Platelet-derived endothelial cell growth factor/thymidine phosphorylase expression in normal tissues: An immunohistochemical study. J. Pathol. 1995; 176: 183-190.
36. 36 Haba A, Monden T, Sekimoto M et al. PyNPase expression in human colon cancer. Cancer Lett. 1998; 122: 85-92.
37. 37 Miyazono K, Heldin CH. High-yield purification of platelet-derived endothelial cell growth factor: Structural characterization and establishment of a specific antiserum. Biochemistry 1989; 28: 1704-1710.
38. 38 Furukawa T, Yoshimura A, Sumizawa T et al. Angiogenic factor. Nature 1992; 356: 668.
39. 39 Leung DW, Cachianes G, Kuang W-J, Goeddel DV, Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989; 246: 1306-1309.
40. 40 Fidler IJ, Ellis LM. The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell 1994; 79: 185-188.
41. 41 Chu E, Copur S, Jones KL et al. Thymidylate synthase regulates the translation of p53 mRNA. Proc. Am. Assoc. Cancer Res. 1995; 36: 563.
42. 42 Kieser A, Weich HA, Brandner G, Marme D, Kolch W. Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression. Oncogens 1994; 9: 963-969.
43. 43 Baas IO, Mulder J-WR, Offerhaus GJA, Vogelstein B, Hamilton SR. An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms. J. Pathol. 1994; 172: 5-12.
44. 44 Ishida M, Gomyo Y, Ohfuji S, Ikeda M, Kawasaki H, Ito H. Evidence that expression of a mutated p53 gene attenuates apoptotic cell death in human gastric intestinal-type carcinomas in vivo. Jpn. J. Cancer Res. 1997; 88: 468-475.
45. 45 Ho CK, Ou BR, Hsu ML, Su SN, Yung CH, Wang SY. Induction of thymidine kinase activity and clonal growth of certain leukemic cell lines by a granulocyte-derived factor. Blood 1990; 75: 2438-2444.
46. 46 Eda H, Fujimoto K, Watanabe S et al. Cytokines induce thymidine phosphorylase expression in tumor cell and make them more susceptible to 5′-deoxy-5-fluorouridine. Cancer Chemother. Pharmacol. 1993; 32: 333-338.
47. 47 Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992; 359: 843-845.